Research in Education and Learning Innovation Archives, 2019 En este artículo se describe la metodología que se ha denominado Aprendizaje Basado en Problemas-Proyectos Adaptativos y Creativos (ABPac), utilizando como ejemplo algunos de los proyectos realizados en el centro concertado Jesús-María de Burgos durante ...
Miguel Ángel Queiruga-Dios +2 more
doaj +1 more source
Zhejiang Daxue xuebao. Lixue ban, 2000 黄瓜子叶培养物在pH7.0的培养基上培养1d而后转入正常培养基（pH5.8），能显著提高黄瓜子叶培养物的成花率。对pH7.0处理1d的子叶柄中游离IAA含量水平的检测表明：pH7.0处理降低了子叶柄中IAA的含量水平；ABP基因的表达情况均高于对照组。因此pH7.0处理对黄瓜子叶柄同时具有促进ABP基因表达和降低游离IAA含量水平的作用。
DUQin(杜勤) +3 more
doaj +1 more source
Pharmacokinetic Comparability of ABP 654, a Biosimilar to Ustekinumab, Administered Either via Prefilled Syringe or Autoinjector in Healthy Adults: Results from a Randomized, Open‐Label, Parallel‐Group Study [PDF]
Clinical Pharmacology in Drug DevelopmentAbstract ABP 654, a biosimilar to ustekinumab reference product, is available in a prefilled syringe (PFS) for subcutaneous (SC) use. The ABP 654 autoinjector pen (AIP) has recently been developed with an aim to improve the injection experience for patients and caregivers.
Chow V +8 more
europepmc +2 more sources
Weakening Assumptions for Deterministic Subexponential Time Non-Singular Matrix Completion [PDF]
, 2009 In (Kabanets, Impagliazzo, 2004) it is shown how to decide the circuit polynomial identity testing problem (CPIT) in deterministic subexponential time, assuming hardness of some explicit multilinear polynomial family for arithmetical circuits.
Jansen, Maurice
core +6 more sources
Analytical and functional similarity of Amgen biosimilar ABP 215 to bevacizumab
mAbs, 2018 ABP 215 is a biosimilar product to bevacizumab. Bevacizumab acts by binding to vascular endothelial growth factor A, inhibiting endothelial cell proliferation and new blood vessel formation, thereby leading to tumor vasculature normalization. The ABP 215
Neungseon Seo +9 more
semanticscholar +1 more source
The Roles of Gene Duplication, Gene Conversion and Positive Selection in Rodent \u3ci\u3eEsp\u3c/i\u3e and \u3ci\u3eMup\u3c/i\u3e Pheromone Gene Families with Comparison to the \u3ci\u3eAbp\u3c/i\u3e Family [PDF]
, 2012 Three proteinaceous pheromone families, the androgen-binding proteins (ABPs), the exocrine-gland secreting peptides (ESPs) and the major urinary proteins (MUPs) are encoded by large gene families in the genomes of Mus musculus and Rattus norvegicus.
Karn, Robert C., Laukaitis, Christina M.
core +4 more sources
Advances in Therapy, 2019 ABP 501 [United States: AMJEVITA™ (adalimumab-atto); European Union: AMGEVITA® (adalimumab)] is the first approved biosimilar to adalimumab [reference product (RP)], a monoclonal antibody (mAb) targeting tumor necrosis factor-alfa (TNF-α).
R. Markus +6 more
semanticscholar +1 more source
The Journal of Clinical Hypertension, 2021 The agreement between the traditionally‐used ambulatory blood pressure (ABP)‐load thresholds in children and recently‐recommended pediatric American Heart Association (AHA)/European Society of Hypertension (ESH) ABP thresholds for diagnosing ambulatory ...
Ajay P. Sharma +6 more
doaj +1 more source
Subject-Based Model for Reconstructing Arterial Blood Pressure from Photoplethysmogram
Bioengineering, 2022 The continuous prediction of arterial blood pressure (ABP) waveforms via non-invasive methods is of great significance for the prevention and treatment of cardiovascular disease.
Qunfeng Tang +4 more
doaj +1 more source
Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab
BioDrugs, 2019 ABP 980 has been developed as a biosimilar to Herceptin® (trastuzumab). Comprehensive analytical characterization incorporating orthogonal analytical techniques was used to compare ABP 980 to trastuzumab reference products sourced from the United States (
K. Hutterer +5 more
semanticscholar +1 more source